岩藻多糖的药理作用研究进展

doi:10.7501/j.issn.1674-5515.2023.07.041

首页 > 过刊浏览>2023年第38卷第7期 >2023,38(7):1786-1792. DOI:10.7501/j.issn.1674-5515.2023.07.041

岩藻多糖的药理作用研究进展

唐欢欢
唐欢欢
海南医学院第一附属医院呼吸内科, 海南海口 570102
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
李琪
李琪
海南医学院第一附属医院呼吸内科, 海南海口 570102;国家卫生健康委员会热带病防治重点实验室, 海南海口 571199;海南省呼吸疾病临床医学中心, 海南海口 571199
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
周向东
周向东
海南医学院第一附属医院呼吸内科, 海南海口 570102;国家卫生健康委员会热带病防治重点实验室, 海南海口 571199;海南省呼吸疾病临床医学中心, 海南海口 571199
通讯作者.
Email: zxd999@263.net
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找

Research progress on pharmacological effects of fucoidan

TANG Huan-huan
TANG Huan-huan
Department of Respiratory Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
LI Qi
LI Qi
Department of Respiratory Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China;National Health Commission Key Laboratory of Tropical Disease Control, Haikou 571199, China;Hainan Respiratory Disease Clinical Medical Center, Haikou 571199, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
ZHOU Xiang-dong
ZHOU Xiang-dong
Department of Respiratory Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China;National Health Commission Key Laboratory of Tropical Disease Control, Haikou 571199, China;Hainan Respiratory Disease Clinical Medical Center, Haikou 571199, China
Contact Author.
Email: zxd999@263.net
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找

发布日期：2023-07-22

摘要
图/表
访问统计
PDF预览
参考文献
相似文献
引证文献
附件

[关键词]

岩藻多糖 ; 抗炎 ; 抗肿瘤 ; 神经保护 ; 抗凝 ; 调节肠道菌群 ; 调节血脂 ; 抗病毒作用

[摘要]

岩藻多糖是从褐藻细胞壁和细胞间质中分离得到的一类天然硫酸化杂多糖。岩藻多糖具有多样的生物活性，如抗炎、抗肿瘤、神经保护、抗凝、调节肠道菌群、调节血脂、抗病毒作用。对岩藻多糖的药理作用进行了总结，以期为进一步开发利用岩藻多糖提供参考。

[Key word]

fucoidan ; anti-inflammatory ; anti-tumor ; neuroprotection ; anticoagulation ; regulation of intestinal flora ; regulation of blood lipids ; antiviral effect

[Abstract]

Fucoidan is a type of natural sulfated heteropolysaccharides isolated from the cell wall and intercellular matrix of brown algae. Fucoidan has various biological activities, such as anti-inflammatory, anti-tumor, neuroprotection, anticoagulation, regulation of intestinal flora, regulation of blood lipids, and antiviral effect. This article introduces the functions of fucoidan, hoping to provide reference for further development and utilization of fucoidan.

[中图分类号]

R285.5

[基金项目]

国家重点研发计划（2022YFC2305004）；国家自然科学基金资助项目（82260001，82160012）；海南省重大科技专项（ZDKJ2021036）；海南省重点研发项目（ZDYF2020223）；海南省重点研发计划国际科技合作项目（GHYF2022011）；海南省创新团队项目（820CXTD448）

[1] Cuong H D, Thuy T T T, Huong T T, et al. Structure and hypolipidaemic activity of fucoidan extracted from brown seaweed Sargassum henslowianum [J]. Nat Prod Res, 2014, 29(5): 411-415.

[2] Cui Y, Zhu L, Li Y, et al. Structure of a laminarin-type β- (1→3)-glucan from brown algae Sargassum henslowianum and its potential on regulating gut microbiota [J]. Carbohyd Polym, 2020, 255: 117389.

[3] Tsirigoti A, Beakes G W, Hervé C, et al. Attachment, penetration and early host defense mechanisms during the infection of filamentous brown algae by Eurychasma dicksonii [J]. Protoplasma, 2015, 252(3): 845-856.

[4] Qin L, Hu C, Feng J, et al. Activation of lymphocytes induced by bronchial epithelial cells with prolonged RSV infection [J]. PLoS One, 2011, 6(12): e27113.

[5] Yang C, Tian J, Ko W, et al. Oligo-fucoidan improved unbalance the Th1/Th2 and Treg/Th17 ratios in asthmatic patients: An ex vivo study [J]. Exp Ther Med, 2018, 17(1): 3-10.

[6] Pokharel Y R, Yoon S Y, Kim S K, et al. Inhibition of acrolein-stimulated MUC5AC production by fucoidan in human bronchial epithelial cells [J]. Die Pharmazie, 2008, 63(10): 757-759.

[7] Ni L, Wang L, Fu X, et al. In vitro and in vivo anti- inflammatory activities of a fucose-rich fucoidan isolated from Saccharina japonica [J]. Int J Biol Macromol, 2020, 156(1): 717-729.

[8] Ahmad T, Ishaq M, Karpiniec S, et al. Oral macrocystis pyrifera fucoidan administration exhibits anti-inflammatory and antioxidant properties and improves DSS-induced colitis in C57BL/6J mice [J]. Pharmaceutics, 2022, 14(11): 2383.

[9] 林媛. 基于Notch信号探讨岩藻多糖对人结肠上皮细胞炎症损伤的保护作用 [D]. 青岛: 青岛大学, 2020.

[10] Hsu H, Lin T, Hu C, et al. Fucoidan upregulates TLR4/ CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells [J]. Cancer Lett, 2018, 432: 112-120.

[11] Chantree P, Na-bangchang K, Martviset P. Anticancer activity of fucoidan via apoptosis and cell cycle arrest on cholangiocarcinoma cell [J]. Asian Pac J Cancer Prev, 2021, 22(1): 209-217.

[12] Arumugam P, Arunkumar K, Sivakumar L, et al. Anticancer effect of fucoidan on cell proliferation, cell cycle progression, genetic damage and apoptotic cell death in HepG2 cancer cells [J]. Toxicol Rep, 2019, 6: 556-563.

[13] Zhang Z, Teruya K, Yoshida T, et al. Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells [J]. Mar Drugs, 2013, 11(1): 81-98.

[14] Song Z, Wang J, Su Q, et al. The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma [J]. Braz J Otorhinolaryngol, 2019, 87(5): 521-528.

[15] Lee H, Kim J, Kim E. Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways [J]. PloS One, 2012, 7(11): e50624.

[16] Pinheiro A C, Bourbon A I, Cerqueira M A, et al. Chitosan/fucoidan multilayer nanocapsules as a vehicle for controlled release of bioactive compounds [J]. Carbohydr Polym, 2015: 115: 1-9.

[17] Kimura R, Rokkaku T, Takeda S, et al. Cytotoxic effects of fucoidan nanoparticles against osteosarcoma [J]. Mar Drugs, 2013, 11(11): 4267-4278.

[18] Pawar V K, Singh Y, Sharma K, et al. Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin [J]. Int J Biol Macromol, 2018, 122: 1100-1114.

[19] Takahashi H, Kawaguchi M, Kitamura K, et al. An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients [J]. Integr Cancer Ther, 2018, 17(2): 282-291.

[20] 巨虎, 刘川川, 王虎, 等. 岩藻多糖调节JAK2/STAT3信号通路保护神经元免受缺氧缺糖/再灌注损伤 [J]. 中国高原医学与生物学杂志, 2022, 43(1): 7-17.

[21] Kim H, Ahn J H, Song M, et al. Pretreated fucoidan confers neuroprotection against transient global cerebral ischemic injury in the gerbil hippocampal CA1 area via reducing of glial cell activation and oxidative stress [J]. Biomed Pharmacother, 2019, 109: 1718-1727.

[22] Alghazwi M, Smid S, Karpiniec S, et al. Comparative study on neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida [J]. Int J Biol Macromol, 2018, 122: 255-264.

[23] Sakai C, Abe S, Kouzuki M, et al. A randomized placebo- controlled trial of an oral preparation of high molecular weight fucoidan in patients with type 2 diabetes with evaluation of taste sensitivity [J]. Yonago Acta Med, 2019, 62(1): 14-23.

[24] Choi Y, Min S, Usoltseva R, et al. Thrombolytic fucoidans inhibit the tPA-PAI1 complex, indicating activation of plasma tissue-type plasminogen activator is a mechanism of fucoidan-mediated thrombolysis in a mouse thrombosis model [J]. Throm Res, 2017, 161: 22- 25.

[25] Juenet M, Aid-launais R, Li B, et al. Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin [J]. Biomaterials, 2017, 156: 204-216.

[26] Bonnard T, Yang G, Petiet A, et al. Abdominal aortic aneurysms targeted by functionalized polysaccharide microparticles: A new tool for SPECT imaging [J]. Theranostics, 2014, 4(6): 592-603.

[27] Abdollah M R A, Carter T J, Jones C, et al. Fucoidan prolongs the circulation time of dextran-coated iron oxide nanoparticles [J]. ACS Nano, 2018, 12(2): 1156-1169.

[28] Jordan S, Tung N, Casanova-acebes M, et al. Dietary intake regulates the circulating inflammatory monocyte pool [J]. Cell, 2019, 178(5): 1102-1114.e17.

[29] Dicksved J, Halfvarson J, Rosenquist M, et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease [J]. ISME J, 2008, 2(7): 716-727.

[30] Bisanz J E, Soto-perez P, Noecker C, et al. A Genomic toolkit for the mechanistic dissection of intractable human gut bacteria [J]. Cell Host Microbe, 2020, 27(6): 1001-1013.e9.

[31] 陈燕, 李旭, 郝迪, 等. 消炎汤调节肠道微生态改善大鼠慢性盆腔炎的研究 [J]. 现代药物与临床, 2020, 35(5): 849-853.

[32] Xue M, Ji X, Li W. The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer [J]. Food Funct, 2018, 9(2): 1214-1223.

[33] 黄娟, 黄金莉, 孙佳悦, 等. 岩藻多糖对免疫低下小鼠模型免疫功能和肠道菌群的调节作用 [J]. 中国食品学报, 2022, 22(5): 92-102.

[34] Fujimori S. Progress in elucidating the relationship between Helicobacter pylori infection and intestinal diseases [J]. World J Gastroenterol, 2021, 27(47): 8040- 8046.

[35] 张雪琳, 蒋晨, 徐珊, 等. 岩藻多糖对幽门螺杆菌感染后小鼠肠道菌群紊乱的调节作用 [J]. 精准医学杂志, 2021, 36(3): 222-226.

[36] 杨佳, 党凯, 薛美兰, 等. 岩藻多糖对酒精暴露小鼠肝损伤的保护作用及机制 [J]. 食品科学, 2023, 44(3): 137-145.

[37] 黄金莉. 岩藻多糖对饮食诱导ICR小鼠肥胖相关高脂血症的预防及其肠道菌群调节作用的研究 [D]. 大连: 大连医科大学, 2021.

[38] Eo H, Jeon Y, Lee M, et al. Brown alga Ecklonia cava polyphenol extract ameliorates hepatic lipogenesis, oxidative stress, and inflammation by activation of AMPK and SIRT1 in high-fat diet-induced obese mice [J]. J Agr Food Chem, 2015, 63(1): 349-359.

[39] Yandrapalli S, Aronow W S, Frishman W H. Readmissions in adult patients following hospitalization for influenza: A nationwide cohort study [J]. Ann Transl Med, 2018, 6(16): 318.

[40] Wang W, Wu J, Zhang X, et al. Inhibition of influenza A virus infection by fucoidan targeting viral neuraminidase and cellular EGFR pathway [J]. Sci Rep, 2017, 7: 40760.

[41] Yamada K, Miyoshi H, Yoshida N, et al. Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia/lymphoma [J]. Mod Pathol, 2021, 34(2): 314-326.

[42] Araya N, Takahashi K, Sato T, et al. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease [J]. Antivir Ther, 2011, 16(1): 89-98.

[43] Tsubura S, Suzuki A. Case report using 4% fucoidan cream for recurrent oral herpes labialis: Patient symptoms markedly improved in terms of time to healing and time to loss of discomfort [J]. Dent Open, 2018, 5(1): 6-10.